Literature DB >> 8407563

Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.

H Watanabe1, N Sawabu, H Ohta, Y Satomura, O Yamakawa, Y Motoo, T Okai, H Takahashi, T Wakabayashi.   

Abstract

Pancreatic cancer is detected on the basis of morphological changes delineated by means of various image-diagnostic methods. However, differentiation between chronic pancreatitis and pancreatic cancer, especially at the early stage, is not always simple when based upon the morphological changes alone. Therefore, we attempted to elucidate K-ras mutations in the sediment of pure pancreatic juice (PPJ) containing exfoliated ductal pancreatic cancer cells. PPJ was collected endoscopically from 20 patients with pancreatic cancer (PC) and 18 patients with chronic pancreatitis (CP). Polymerase chain reaction and allele specific oligonucleotide dot blot hybridization for K-ras mutations were performed with the DNA extracted from these samples. A K-ras mutation at codon 12 was identified in the PPJ of 11/20 (55%) of the patients with PC. On the other hand, the same mutation was not identified in the PPJ of any patient with CP. Moreover, K-ras mutations at codons 13 and 61 were not recognized in the PPJ of any patient with either PC or CP. These findings suggested that the presence of a K-ras mutation at codon 12 in PPJ would be useful in confirming the diagnosis of PC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407563      PMCID: PMC5919281          DOI: 10.1111/j.1349-7006.1993.tb00185.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Cytological diagnosis of pancreatic tumors.

Authors:  E Bodner; K Schwamberger; G Mikuz
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

4.  Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases.

Authors:  M Tada; M Omata; M Ohto
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

5.  Diagnostic significance of cancer-associated carbohydrate antigen (CA19-9) concentrations in pancreatic juice: analysis in pure pancreatic juice collected by endoscopic aspiration and immunohistochemical study in chronic pancreatitis.

Authors:  T Wakabayashi; N Sawabu; Y Takemori; Y Satomura; H Kidani; H Ohta; H Watanabe; O Yamakawa; H Takahashi; K Watanabe
Journal:  Pancreas       Date:  1993-03       Impact factor: 3.327

6.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.

Authors:  M Tada; M Omata; M Ohto
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

8.  High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.

Authors:  K Grünewald; J Lyons; A Fröhlich; H Feichtinger; R A Weger; G Schwab; J W Janssen; C R Bartram
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

9.  Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.

Authors:  M Mariyama; K Kishi; K Nakamura; H Obata; S Nishimura
Journal:  Jpn J Cancer Res       Date:  1989-07

10.  Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese.

Authors:  Y Nagata; M Abe; K Motoshima; E Nakayama; H Shiku
Journal:  Jpn J Cancer Res       Date:  1990-02
View more
  19 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

Review 3.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

Review 4.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

5.  Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.

Authors:  D B Evans; M L Frazier; C Charnsangavej; R L Katz; L Larry; J L Abbruzzese
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

6.  Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.

Authors:  L Theodor; E Melzer; M Sologov; G Idelman; E Friedman; S Bar-Meir
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

8.  Clinical significance of K-ras oncogene activation in ampullary neoplasms.

Authors:  C H Chung; R E Wilentz; M M Polak; T B Ramsoekh; L A Noorduyn; D J Gouma; K Huibregtse; G J Offerhaus; R J Slebos
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

Review 9.  Pancreatic cancer and the FAMMM syndrome.

Authors:  Henry T Lynch; Ramon M Fusaro; Jane F Lynch; Randall Brand
Journal:  Fam Cancer       Date:  2007-11-09       Impact factor: 2.375

Review 10.  Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.

Authors:  H Friess; P Berberat; M Schilling; J Kunz; M Korc; M W Büchler
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.